Pressure BioSciences Inc. (PBIO) Issues Update on
Post# of 1354
(Total Views: 192)
Posted On: 09/24/2019 4:53:16 PM
Pressure BioSciences Inc. (PBIO) Issues Update on Guidance for Revenue Growth and Success of Revolutionary CBD Oil Processing System
- The company believes that its total revenue will more than double in 2020, led by commercialization of its revolutionary CBD oil nanoemulsification system
- PBIO’s BaroShear K45, based on the company’s proprietary Ultra Shear Technology (UST) platform, revolutionizes the manufacture of water-soluble, long-term, stable, highly absorbable, nanoemulsified CBD oil
- The worldwide CBD market is expected to reach $20 billion in sales by 2024, with competition ramping up as CBD manufacturers seek new ways to stand out
- PBIO has announced three pre-sales of its BaroShear K45 nanoemulsification system for making water-soluble CBD Oil
- Progress continues on the build-out of its GMP-compliant manufacturing laboratory to showcase the BaroShear K45 and its industrial scale, high volume UST-based nanoemulsification systems (release date to be determined)
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, expects its total revenues to more than double in 2020 following the successful launch of its revolutionary CBD (cannabidiol) processing system – the BaroShear K45. This novel processing system creates a water-soluble CBD oil that disperses instantly in liquid, providing enhanced quality and bio-absorption (http://nnw.fm/4fGre).
Development of the BaroShear K45 system began following the company’s in-depth analysis of the CBD market, which showed a common, yet critical production issue facing CBD manufacturers – the poor water solubility of today’s oil-based CBD products means that the beneficial properties of CBD are inadequately available for absorption in the body.
“After much diligence and analysis, we concluded that we have the expertise and experience to successfully address this critical issue,” Richard T. Schumacher, president and CEO of PBIO, stated in an August 2019 shareholder report (http://nnw.fm/wXV6R). “Consequently, we pulled significant hours away from many of our staff over the past few months and had them focus on the development of an instrument system – based on our patented UST platform – that would increase the water-solubility, and thus the absorption, of CBD Oil. We succeeded; the result of that success is the BaroShear K45 processing system.”
The collective market for CBD sales in the U.S. is expected to exceed $20 billion by 2024, according to a new report from BDS Analytics and Arcview Market Research (http://nnw.fm/vX8CI). The forecast includes products sold through licensed dispensaries and general retail outlets such as grocery stores, mass merchants and pharmacies. Standing out from the crowded field of competitors will be essential for any business pursuing the spotlight in a rapidly expanding CBD marketplace.
“To survive, companies will need to differentiate themselves from the competition by delivering the highest quality products possible,” Schumacher added. “Such products would undoubtedly need to have high water-solubility, absorption, and bioavailability, along with long shelf-life and a minimal amount of added chemicals. This is exactly what we intend to deliver.”
PBIO announced the initial sale of the BaroShear K45 processing system to its first customer, Nano CBD Cosmetics LLC, in an earlier news release (http://nnw.fm/8ajO9). Nano CBD Cosmetics founder and CEO Christopher Holden expressed excitement with his company’s purchase.
“We are thrilled to be the first purchaser of the BaroShear K45 system,” Holden stated in the release. “This groundbreaking technology will enable companies producing nano-scale CBD emulsion products to meet the ever-increasing demand for CBD nanoemulsion products. In fact, our own nano-CBD products are currently selling faster than we can produce them. However, with PBIO’s cutting-edge technology, we expect to increase our nano-emulsified, water-soluble CBD production capacity to many multiples of what it is today… and that is huge.”
Following the announcement of its initial pre-sale, PBIO has continued to pre-sell additional, limited quantities of the BaroShear K45. The company recently announced two additional pre-sales of the K45 system (http://nnw.fm/1Zuz9) – one to NanoPeak Solutions Inc., a private company located in Vancouver, British Columbia, and the second to a private company in Las Vegas, Nevada. This leaves just nine remaining systems available for the PBIO pre-sell program. Units sold over the coming weeks are on track to be delivered and installed in the first half of 2020.
“We believe that such sales will have a significant impact on 2020 total revenue, potentially resulting in more than twice the total revenue of 2019,” Schumacher stated in a news release. “We further believe that revenue from our BaroFold platform contract services will continue to increase, and that the decline in PCT platform instrument sales observed over the past two quarters (caused in part by our focus on the development of the BaroShear K45) will end, and that we will see an increase in PCT product sales over the second half of 2019, and beyond.”
Two short videos released by PBIO (http://nnw.fm/2qOQV and http://nnw.fm/opQ3D), showing how its patented UST platform is able to process CBD plant oil into a water-soluble nanoemulsion, give a quick lesson in PBIO’s proprietary technology.
For more information, visit the company’s website at www.PressureBioSciences.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- The company believes that its total revenue will more than double in 2020, led by commercialization of its revolutionary CBD oil nanoemulsification system
- PBIO’s BaroShear K45, based on the company’s proprietary Ultra Shear Technology (UST) platform, revolutionizes the manufacture of water-soluble, long-term, stable, highly absorbable, nanoemulsified CBD oil
- The worldwide CBD market is expected to reach $20 billion in sales by 2024, with competition ramping up as CBD manufacturers seek new ways to stand out
- PBIO has announced three pre-sales of its BaroShear K45 nanoemulsification system for making water-soluble CBD Oil
- Progress continues on the build-out of its GMP-compliant manufacturing laboratory to showcase the BaroShear K45 and its industrial scale, high volume UST-based nanoemulsification systems (release date to be determined)
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, expects its total revenues to more than double in 2020 following the successful launch of its revolutionary CBD (cannabidiol) processing system – the BaroShear K45. This novel processing system creates a water-soluble CBD oil that disperses instantly in liquid, providing enhanced quality and bio-absorption (http://nnw.fm/4fGre).
Development of the BaroShear K45 system began following the company’s in-depth analysis of the CBD market, which showed a common, yet critical production issue facing CBD manufacturers – the poor water solubility of today’s oil-based CBD products means that the beneficial properties of CBD are inadequately available for absorption in the body.
“After much diligence and analysis, we concluded that we have the expertise and experience to successfully address this critical issue,” Richard T. Schumacher, president and CEO of PBIO, stated in an August 2019 shareholder report (http://nnw.fm/wXV6R). “Consequently, we pulled significant hours away from many of our staff over the past few months and had them focus on the development of an instrument system – based on our patented UST platform – that would increase the water-solubility, and thus the absorption, of CBD Oil. We succeeded; the result of that success is the BaroShear K45 processing system.”
The collective market for CBD sales in the U.S. is expected to exceed $20 billion by 2024, according to a new report from BDS Analytics and Arcview Market Research (http://nnw.fm/vX8CI). The forecast includes products sold through licensed dispensaries and general retail outlets such as grocery stores, mass merchants and pharmacies. Standing out from the crowded field of competitors will be essential for any business pursuing the spotlight in a rapidly expanding CBD marketplace.
“To survive, companies will need to differentiate themselves from the competition by delivering the highest quality products possible,” Schumacher added. “Such products would undoubtedly need to have high water-solubility, absorption, and bioavailability, along with long shelf-life and a minimal amount of added chemicals. This is exactly what we intend to deliver.”
PBIO announced the initial sale of the BaroShear K45 processing system to its first customer, Nano CBD Cosmetics LLC, in an earlier news release (http://nnw.fm/8ajO9). Nano CBD Cosmetics founder and CEO Christopher Holden expressed excitement with his company’s purchase.
“We are thrilled to be the first purchaser of the BaroShear K45 system,” Holden stated in the release. “This groundbreaking technology will enable companies producing nano-scale CBD emulsion products to meet the ever-increasing demand for CBD nanoemulsion products. In fact, our own nano-CBD products are currently selling faster than we can produce them. However, with PBIO’s cutting-edge technology, we expect to increase our nano-emulsified, water-soluble CBD production capacity to many multiples of what it is today… and that is huge.”
Following the announcement of its initial pre-sale, PBIO has continued to pre-sell additional, limited quantities of the BaroShear K45. The company recently announced two additional pre-sales of the K45 system (http://nnw.fm/1Zuz9) – one to NanoPeak Solutions Inc., a private company located in Vancouver, British Columbia, and the second to a private company in Las Vegas, Nevada. This leaves just nine remaining systems available for the PBIO pre-sell program. Units sold over the coming weeks are on track to be delivered and installed in the first half of 2020.
“We believe that such sales will have a significant impact on 2020 total revenue, potentially resulting in more than twice the total revenue of 2019,” Schumacher stated in a news release. “We further believe that revenue from our BaroFold platform contract services will continue to increase, and that the decline in PCT platform instrument sales observed over the past two quarters (caused in part by our focus on the development of the BaroShear K45) will end, and that we will see an increase in PCT product sales over the second half of 2019, and beyond.”
Two short videos released by PBIO (http://nnw.fm/2qOQV and http://nnw.fm/opQ3D), showing how its patented UST platform is able to process CBD plant oil into a water-soluble nanoemulsion, give a quick lesson in PBIO’s proprietary technology.
For more information, visit the company’s website at www.PressureBioSciences.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼